Kymera Therapeutics Inc. (KYMR)
NASDAQ · Healthcare
Kymera Therapeutics Inc. Revenue 2019–2025
Kymera Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Kymera Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 34.4 M, a 55.50% increase year-over-year.
- Kymera Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 70.7 M, a 59.22% increase year-over-year.
- Kymera Therapeutics Inc. annual revenue for 2025 was 39.2 M, a 16.70% decrease from 2024.
- Kymera Therapeutics Inc. annual revenue for 2024 was 47.1 M, a 40.11% decrease from 2023.
- Kymera Therapeutics Inc. annual revenue for 2023 was 78.6 M, a 67.84% increase from 2022.
- Kymera Therapeutics Inc. annual revenue for 2022 was 46.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kymera Therapeutics Inc. Market Cap — FAQ
Kymera Therapeutics Inc. (KYMR) market cap over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYMR's market cap history?
The chart and table above show Kymera Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.